EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria

Christelle M Vandervelde iD, Anthony Meyers, Anaïs David, Sofian Bouneb iD, Stephanie Everaerts iD, Wim Janssens iD, Walter Weder iD, Laurens J Ceulemans iD

Interdisciplinary CardioVascular and Thoracic Surgery · 01.12.2025 · 40 (12)

DOI: 10.1093/icvts/ivaf274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 18.11.2025. Verfasst von Christelle M Vandervelde und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Pneumonectomy, Pulmonary Emphysema, Patient Selection, Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Hospitals Leuven (KOOR) and research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Lung volume reduction surgery (LVRS) is guided by strict selection criteria from the National Emphysema Treatment Trial (NETT) to minimize risk and optimize outcomes. However, emerging evidence suggests that rigid cutoffs may exclude patients who could benefit. This study aimed to identify beyond-criteria patients undergoing LVRS and compare their outcomes with standard-criteria patients.

Methods

This single-centre retrospective analysis of a prospectively maintained database included all LVRS procedures from August 2019 until November 2024. Patients were classified as beyond-criteria if they met two or more of the following: age ≥ 75 years, body mass index (BMI) < 18.5 kg/m2, forced expiratory volume in 1 second (FEV1) < 20%pred, diffusing capacity for carbon monoxide (DLCO) < 20%pred, 6-minute walk distance (6MWD) < 140 m, homogeneous emphysema, systolic pulmonary arterial pressure (sPAP) > 35 mmHg, or prior thoracic interventions. Complications (Clavien-Dindo) and functional outcomes were assessed at 3, 6, and 12 months.

Results

Twenty-one procedures were performed in 18 beyond-criteria patients versus 227 procedures in 191 standard-criteria patients. Among beyond-criteria patients: age ≥ 75 years (n = 3), BMI < 18.5 kg/m2 (n = 10), FEV1 < 20%pred (n = 5), DLCO < 20%pred (n = 1), 6MWD < 140 m (n = 1), homogeneous emphysema (n = 3), sPAP > 35 mmHg (n = 12), and prior thoracic intervention (n = 7). Complication rates were comparable (38% vs. 42%, P = .819 [95% CI, 0.93-1.10]), as were prolonged air leaks and hospital stay. One 30-day LVRS-related death (0.4%) occurred in the standard group. Functional and quality of life measures improved in both groups.

Conclusions

Beyond-criteria patients can be considered for LVRS when guided by careful multidisciplinary evaluation, with meaningful improvement in experienced centers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PneumonectomyPulmonary EmphysemaPatient SelectionLungHumansMaleAgedFemaleRetrospective StudiesTreatment OutcomeAged, 80 and overMiddle AgedTime FactorsPostoperative ComplicationsRisk FactorsDatabases, FactualRecovery of Function

Stichwörter der Autor:innen

COPDemphysemalung volume reduction surgeryselection criteria

Autor:innen und Institutionen

  • Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium.
  • Department of Chronic Diseases and Metabolism Laboratory of Pneumology and Thoracic Surgery (BREATHE), KU Leuven, Leuven, Belgium.
  • Department of Anaesthesiology, University Hospitals Leuven, Leuven, Belgium.
  • Department of Cardiovascular Sciences, Division of Anaesthesiology and Algology, KU Leuven, Leuven, Belgium.
  • Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium.
  • Department of Thoracic Surgery, Klinik Bethanien, Zurich, Switzerland.

ORCID-Profile: Christelle M Vandervelde, Sofian Bouneb, Stephanie Everaerts, Wim Janssens, Walter Weder, Laurens J Ceulemans

Förderung

  • University Hospitals Leuven (KOOR) and research Foundation Flanders

Zitieren

APA

Vandervelde, C. M., Meyers, A., David, A., Bouneb, S., Everaerts, S., Janssens, W., Weder, W., & Ceulemans, L. J. (2025). Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria. Interdisciplinary CardioVascular and Thoracic Surgery, 40(12). https://doi.org/10.1093/icvts/ivaf274

Vancouver

Vandervelde CM, Meyers A, David A, Bouneb S, Everaerts S, Janssens W, et al. Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria. Interdisciplinary CardioVascular and Thoracic Surgery. 2025;40(12). doi:10.1093/icvts/ivaf274

BibTeX
@article{Vandervelde2025,
  author = {Vandervelde, Christelle M and Meyers, Anthony and David, Anaïs and Bouneb, Sofian and Everaerts, Stephanie and Janssens, Wim and Weder, Walter and Ceulemans, Laurens J},
  title = {Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2025},
  volume = {40},
  number = {12},
  doi = {10.1093/icvts/ivaf274}
}
Kostenlos starten →